Cargando…
Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
PURPOSE: The role of adjuvant postmastectomy radiotherapy (PMRT) remains controversial for patients with pT3N0M0 breast cancer, especially when patients are treated with the updated adjuvant chemotherapy. Our study aimed to compare locoregional recurrence-free survival (LRFS), disease-free survival...
Autores principales: | Li, Chunyan, Wang, Jiangfeng, Mo, Miao, Yuan, Jing, Luo, Jurui, Jin, Kairui, Wang, Xuanyi, Yang, Yilan, Ma, Jinli, Mei, Xin, Yang, Zhaozhi, Yu, Xiaoli, Chen, Xingxing, Guo, Xiaomao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129916/ https://www.ncbi.nlm.nih.gov/pubmed/34017195 http://dx.doi.org/10.2147/CMAR.S309224 |
Ejemplares similares
-
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020) -
Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018) -
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
por: Yang, Yilan, et al.
Publicado: (2022) -
Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
por: Li, Chunyan, et al.
Publicado: (2021) -
CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
por: Yang, Yilan, et al.
Publicado: (2020)